Awarded
6505--Renflexis (infliximab-abda)100MG VIAL Period of Performance 09/01/2023 - 08/31/2024
Awarded tounder 36E79723D0022 (source: SAM.gov award notice)• $119.5M
Overview
- Posted
- May 3, 2023
- Notice type
- Award Notice
Notice details
- Last updated
- Sep 9, 2025
- Award date
- May 3, 2023
- Award amount (SAM.gov award notice)
- $119.5M
Identifiers
- Solicitation number
- 36E79723R0013
- Notice ID
- b73f620ee9014def8acd73ac05e01cf0
- Award number (PIID)
- 36E79723D0022
Description
Award Overview
Award Number
36E79723D0022
Award Amount (SAM.gov award notice)
$119.5M
Award Date
May 3, 2023
Awardee
Awardee UEI
QTT6LXC3YKE9
Original Solicitation
Notice ID: b73f620ee9014def8acd73ac05e01cf0
Posted Date: May 3, 2023
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Oct 19, 2026
- —Signed Sep 10, 2026
- —Signed Aug 21, 2026
- —Signed Jul 21, 2026
- —Signed Jul 6, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36E79723R0013- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Pre-SolicitationFeb 27, 2023
6505--Infliximab Injection 100 mg/vial
- 2×SolicitationMar 13, 2023
6505--Infliximab Injection 100 mg/vial
- AwardedCurrentMay 3, 2023
6505--Renflexis (infliximab-abda)100MG VIAL Period of Performance 09/01/2023 - 08/31/2024
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79723R0013
Archive Date
Jul 2, 2023
Office Address
HINES, IL, 60141